• 4DMT Advances 4D-710 to Phase 2 with Additional Funding and Support from the Cystic Fibrosis Foundation

    Source: Nasdaq GlobeNewswire / 13 Oct 2025 08:00:00   America/New_York

    N/A
Share on,